可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 中华医学会心电生理和起搏分会, 中国生物医学工程学会心脏起搏与电生理分会. 全国心脏起搏器和埋藏式心脏复律除颤器临床应用调查[J]. 中国心脏起搏与心电生理杂志,1998 12(4):175-176.
[2] Marquie C, De Geeter G, Klug D,et al. Postoperative use of heparin increases morbidity of pacemaker implantation[J]. Europace,2006, 8(4):283-287.
[3] Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy[J]. Chest,2004 ,126(4):1177-1186.
[4] Goldstein DJ,Losquadro W,Spotnitz HM. Outpatient pacemaker procedures in oral anticoagulated patients[J]. Pacing Clin Electrophysiol,1998,21(9):1730-1734.
[5] Giudici MC,Paul DL,Bontu P,et al. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy[J]. Pacing Clin Electrophysiol,2004,27(3):358-360.
[6] Michaud GF,Pelosi F Jr, Noble MD,et al. A randomized trial comparing heparin intitiation 6 h or 24 h after pacemaker or defibrillator implantation[J]. Am Coll Cardiol,2000,35(7):1915-1918.
[7] alKhadra AS. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients[J].Pacing Clin Electrophysiol,2003,26(1Pt 2):511-514.